ANTX insider trading
See AN2 Therapeutics (ANTX) insider purchases and sales from SEC Form 4, with trade dates, shares, prices, values and links to the filings.
Insider trades
| Insider | Role | Trade | Traded | Filed | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|
| Eizen Joshua M | See Remarks | Sell | Nov 5, 2026 | Nov 6, 2026 | 2,826 | $4.22 | $11.93K | Filing |
| Readnour Robin Shane | Director | Sell | Sep 9, 2026 | Sep 11, 2026 | 523 | $6.02 | $3.15K | Filing |
| Readnour Robin Shane | Director | Sell | Sep 9, 2026 | Sep 11, 2026 | 585 | $6.02 | $3.52K | Filing |
| Readnour Robin Shane | Director | Sell | Sep 3, 2026 | Sep 8, 2026 | 2,877 | $6.07 | $17.46K | Filing |
| Readnour Robin Shane | Director | Sell | Sep 3, 2026 | Sep 8, 2026 | 3,223 | $6.07 | $19.56K | Filing |
| Readnour Robin Shane | Director | Sell | Sep 8, 2026 | Sep 8, 2026 | 4,725 | $6.02 | $28.44K | Filing |
| Readnour Robin Shane | Director | Sell | Sep 8, 2026 | Sep 8, 2026 | 5,294 | $6.02 | $31.87K | Filing |
| Williams Sarah Joanne | Principal Accounting Officer | Sell | Sep 1, 2026 | Sep 4, 2026 | 272 | $5.53 | $1.50K | Filing |
| FitzPatrick Margaret M | Director | Buy | Sep 1, 2026 | Sep 2, 2026 | 2,098 | $5.53 | $11.60K | Filing |
| Readnour Robin Shane | Director | Sell | Aug 17, 2026 | Aug 19, 2026 | 16,696 | $6.01 | $100.34K | Filing |
| Readnour Robin Shane | Director | Sell | Aug 17, 2026 | Aug 19, 2026 | 18,706 | $6.01 | $112.42K | Filing |
| Eizen Joshua M | See Remarks | Sell | Jul 8, 2026 | Jul 10, 2026 | 5,945 | $4.17 | $24.79K | Filing |
| Williams Sarah Joanne | Principal Accounting Officer | Sell | May 29, 2026 | Jun 2, 2026 | 265 | $4.43 | $1.17K | Filing |
| Williams Sarah Joanne | Principal Accounting Officer | Sell | Mar 3, 2026 | Mar 5, 2026 | 327 | $1.06 | $346.62 | Filing |
| Day Lucy | Chief Financial Officer | Sell | Jan 5, 2026 | Jan 7, 2026 | 3,295 | $1.00 | $3.30K | Filing |
| Day Lucy | Chief Financial Officer | Sell | Jan 6, 2026 | Jan 7, 2026 | 5,512 | $1.01 | $5.58K | Filing |
| Prior Stephen David | Chief Strategy Officer | Sell | Jan 5, 2026 | Jan 7, 2026 | 3,604 | $1.00 | $3.61K | Filing |
| Prior Stephen David | Chief Strategy Officer | Sell | Jan 6, 2026 | Jan 7, 2026 | 2,858 | $1.01 | $2.89K | Filing |
| Chanda Sanjay | Chief Development Officer | Sell | Jan 5, 2026 | Jan 7, 2026 | 3,295 | $1.00 | $3.30K | Filing |
| Chanda Sanjay | Chief Development Officer | Sell | Jan 6, 2026 | Jan 7, 2026 | 5,956 | $1.01 | $6.03K | Filing |
| Eizen Joshua M | See Remarks | Sell | Jan 5, 2026 | Jan 7, 2026 | 17,923 | $1.00 | $17.95K | Filing |
| Eizen Joshua M | See Remarks | Sell | Jan 6, 2026 | Jan 7, 2026 | 6,931 | $1.01 | $7.01K | Filing |
| Eizen Joshua M | See Remarks | Sell | Nov 4, 2025 | Nov 6, 2025 | 2,819 | $1.14 | $3.21K | Filing |
| Prior Stephen David | Chief Strategy Officer | Sell | Nov 4, 2025 | Nov 6, 2025 | 765 | $1.14 | $872.10 | Filing |